Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer

Inclusion Criteria:

Female
Stage 0-III invasive carcinoma of the breast
Surgical resection and axillary assessment, radiation therapy, and/or chemotherapy, as indicated, completed at least 3 months prior to enrollment.
Concomitant trastuzumab and anti-endocrine therapies are permitted. If taking anti-endocrine therapy must have been taking for at least 3 months prior to enrollment.

Must report at least one of the following:

Fatigue in the week prior to enrollment at least 4 on a 10 point scale (with 0 = not tired at all and 10 = extremely tired)
Insomnia in the week prior to enrollment
Pain in the week prior to enrollment at least 4 on a 10 point scale (with 0 = no pain and 10 = extremely severe pain)
Has access to and is able to operate a computer with internet access.
Able to read and understand English.
Willing and able to sign an informed consent document.

Exclusion Criteria:

- Diagnosis of sleep apnea or restless leg syndrome that is currently interfering with sleep